Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Featured Story

    Where to Invest in 2013: What Jim Rogers is Most Optimistic About

    If you're looking for where to invest in 2013, know that the best investment opportunities often come from areas that are out of favor, giving them large potential upside.

    That is what successful contrarian investors such as Jim Rogers and others do. They look for investments where people are rushing out of the 'doors' - creating bargain prices, as opposed to investments where people are clamoring to get into - creating rich valuations.

    So far in 2013, one sector where investors have been rushing out of is the entire commodity space. This has created opportunities for sharp-eyed investors.

    To continue reading, please click here…


    Read More...
  • where to invest 100k